Big Data in Oncology Spotlight
This week in health care trends, our spotlight on big data in oncology includes updates about decreased mortality rates among cancer patients in the United States, 2014 investment highlights from Google Ventures, and a critical look at reimagining electronic health records.
The three articles below are from our dedicated Big Data in Cancer e-magazine. We’re constantly adding valuable content to this updateable magazine, so make sure to check our e-magazine frequently for new intelligence. You can follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular weekly BioBlog emails. (Don’t get our emails yet? Subscribe here!)
Lower Death Rates & More Survivors
A new report by the National Cancer Institute (NCI) has found that the overall death rates due to cancer in the US fell by 22% between 1990 and 2011. Going hand-in-hand with this drop in mortality is a greatly increased number of cancer survivors — from 7 million in 1992 to 14 million in 2011. NCI predicts that “whereas cancer survivors accounted for about 2.5 percent of the U.S. population in 1992, it is estimated that cancer survivors will account for more than 5 percent of the population in 2022.”
In this interactive infographic-like web page, Google shares some of highlights of its investments and business ventures from 2014, including a breakdown of the various types of industries in which they invested (36% in life sciences and health), new companies they welcomed to the Google fold, and a spotlight on data analyzing startup Flatiron Health.
A recent RAND report described electronic health records (EHRs) as “a unique and vexing challenge to physician professional satisfaction.” This HealthAffairs article explores a potential rethinking of EHRs and dealing with big data to “better balance the different strategic needs within care delivery organizations.”